CPAP依从性或可延缓轻度认知障碍合并呼吸暂停老年人的1年认知下降
该准实验性试点临床试验纳入55至89岁、呼吸暂停低通气指数≥10的轻度认知障碍合并阻塞性睡眠呼吸暂停老年人,比较CPAP依从(每晚使用≥4小时,n=29)与非依从(n=25)者1年后的认知与日常功能。结果显示,调整基线差异后,依从组在精神运动/认知处理速度上显著改善,并可能延缓认知下降轨迹。
要点
- CPAP依从定义为每晚使用≥4小时并持续1年。
- 依从组1年精神运动/认知处理速度显著改善,效应量1年达1.25。
- 记忆、注意力、日间嗜睡和日常功能呈现利于依从组的小到中等效应。
核心结论
- 在控制基线差异后,轻度认知障碍合并阻塞性睡眠呼吸暂停老年人坚持CPAP治疗1年可显著改善认知,并可能延缓认知下降轨迹。
研究设计与样本
- 准实验性试点临床试验,纳入55至89岁、呼吸暂停低通气指数≥10的轻度认知障碍合并阻塞性睡眠呼吸暂停老年人,CPAP依从组n=29,非依从组n=25。
主要发现
- 调整年龄、种族和婚姻状况后,依从组较非依从组在1年时精神运动/认知处理速度显著改善(参数估计=1.68;标准误=0.47;95%CI=0.73-2.62),6个月效应量0.46,1年效应量1.25。
- 记忆(6个月效应量0.20)、注意力(1年效应量0.25)、日间嗜睡(6个月效应量0.33,1年效应量0.22)和日常功能(6个月效应量0.50)呈现利于依从组的小到中等效应。
关键数值与推荐
- CPAP依从定义为每晚使用4小时或以上并持续1年。
- 主要认知结局为记忆(Hopkins Verbal Learning Test-Revised),次要认知结局为精神运动/认知处理速度(Wechsler成人智力量表数字符号分测验)。
- 次要功能与进展指标包括日常认知、阿尔茨海默病协作研究-临床总体印象变化量表和临床痴呆评定量表。
临床怎么用
- 对轻度认知障碍合并阻塞性睡眠呼吸暂停的老年患者,应评估并促进CPAP依从性,以可能改善认知处理速度和日常功能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/OBJECTIVES: Obstructive sleep apnea (OSA) has been linked to an increased risk for Alzheimer's disease (AD), but little prospective evidence exists on the effects of OSA treatment in preclinical AD. The objective was to determine if continuous positive airway pressure (CPAP) treatment adherence, controlling for baseline differences, predicts cognitive and everyday function after 1 year in older adults with mild cognitive impairment (MCI) and to determine effect sizes for a larger trial. DESIGN: Quasi-experimental pilot clinical trial with CPAP adherence defined as CPAP use 4 hours or more per night over 1 year. SETTING: Sleep and geriatric clinics and community. PARTICIPANTS: Older adults, aged 55 to 89 years, with an apnea-hypopnea index of 10 or higher participated: (1) MCI, OSA, and CPAP adherent (MCI +CPAP), n = 29; and (2) MCI, OSA, CPAP nonadherent (MCI -CPAP), n = 25. INTERVENTION: CPAP. MEASUREMENTS: The primary cognitive outcome was memory (Hopkins Verbal Learning Test-Revised), and the secondary cognitive outcome was psychomotor/cognitive processing speed (Digit Symbol subtest from the Wechsler Adult Intelligence Scale Substitution Test). Secondary function and progression measures were the Everyday Cognition, Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change Scale, and Clinical Dementia Rating. RESULTS: Statistically significant improvements in psychomotor/cognitive processing speed in the MCI +CPAP group vs the MCI -CPAP group were observed at 1 year after adjustment for age, race, and marital status (parameter estimate = 1.68; standard error = 0.47; 95% confidence interval = 0.73-2.62), with a 6-month effect size (ES) of 0.46 and a 1-year ES of 1.25. There were small to moderate ESs for memory (ES 0.20, 6 mo), attention (ES 0.25, 1 y), daytime sleepiness (ES 0.33, 6 mo and ES 0.22, 1 y), and everyday function (ES 0.50, 6 mo) favoring the MCI +CPAP group vs the MCI -CPAP group. CONCLUSION: Controlling for baseline differences, 1 year of CPAP adherence in MCI +OSA significantly improved cognition, compared with a nonadherent control group, and may slow the trajectory of cognitive decline. TRIAL REGISTRATION NUMBER: Memories; NCT01482351; https://clinicaltrials.gov/ct2/show/NCT01482351?cond=MCI+and+OSA&rank=1 J Am Geriatr Soc 67:558-564, 2019.
引用
- Richards KC, Gooneratne N, Dicicco B, et al. CPAP Adherence May Slow 1-Year Cognitive Decline in Older Adults with Mild Cognitive Impairment and Apnea. J Am Geriatr Soc. 2019. PMID: 30724333. doi:10.1111/jgs.15758
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。